Should You Treat This 72-Year-Old Woman?
Yes, you should treat this patient with levothyroxine. This is overt hypothyroidism with both elevated TSH (5.6 mIU/L) and low free T4 (0.73), which warrants treatment regardless of age.
Rationale for Treatment
This patient has overt hypothyroidism, not subclinical disease. The combination of elevated TSH with low free T4 defines overt hypothyroidism and requires treatment to prevent cardiovascular complications, cognitive decline, and reduced quality of life 1.
Why This TSH Level Matters in a 72-Year-Old
While the French Endocrine Society guidelines note that the upper limit of normal TSH is 7 mIU/L for ages 70-79 years 1, this age-adjusted threshold applies primarily to subclinical hypothyroidism (elevated TSH with normal T4). Your patient has a low T4, which changes the clinical picture entirely and mandates treatment.
The normal T3 level (3.2) does not negate the need for treatment—T3 can remain normal even in overt hypothyroidism due to compensatory mechanisms.
Treatment Initiation Strategy
Starting Dose Considerations
Start with 12.5-25 mcg daily in this elderly patient 2, 3. The FDA label specifically warns about cardiac risks in elderly patients and recommends lower starting doses 3. Even without known coronary disease, patients over 60 years require cautious initiation 2.
Key dosing principles:
- Do NOT start at full replacement dose (1.6 mcg/kg would be ~100 mcg for most patients)
- Elderly patients require 20-25% less levothyroxine per kilogram than younger patients due to decreased lean body mass 2
- Initial dose should be approximately 20 mcg if there are concerns about metabolic clearance 1
If Cardiac Disease Is Present or Suspected
If this patient has known coronary artery disease or develops anginal symptoms:
- Start at 12.5 mcg daily 2
- Monitor closely for chest pain, palpitations, or arrhythmias 3
- Collaborate with cardiology if symptoms emerge—do not withhold necessary treatment, but optimize cardiac management first 4
Monitoring Protocol
Check TSH at 6-8 weeks after starting treatment 1, 3. This timing is critical because levothyroxine has a long half-life and TSH takes weeks to plateau 2.
Dose Adjustment Strategy
- Make small increments of 12.5-25 mcg 2
- Wait another 6-8 weeks before rechecking after each adjustment 1, 3
- Target TSH: within normal-for-age range (upper limit 7 mIU/L for 70-79 years) 1
- Avoid TSH <1 mIU/L to prevent cardiovascular and skeletal complications 1
Once stable, check TSH annually 1.
Critical Pitfalls to Avoid
Overtreatment Risks in the Elderly
The FDA label emphasizes that levothyroxine has a narrow therapeutic index 3. Overtreatment in elderly patients causes:
- Atrial fibrillation (particularly dangerous in this age group) 2, 3
- Accelerated bone loss and osteoporotic fractures 2
- Increased cardiovascular mortality 5
Keep TSH above 1 mIU/L to avoid these complications 1.
Administration Instructions
Instruct the patient to take levothyroxine:
- 30-60 minutes before breakfast with water 2
- Avoid taking with calcium, iron, or other interfering medications 2, 3
- If adherence is problematic, weekly dosing is an acceptable alternative 2
Rule Out Adrenal Insufficiency
Before starting levothyroxine, ensure the patient does not have undiagnosed adrenal insufficiency, as thyroid hormone increases glucocorticoid clearance and can precipitate adrenal crisis 3. This is particularly relevant if there are any signs of central hypothyroidism or autoimmune polyendocrinopathy.
When to Seek Endocrinology Consultation
Consider referral if 1:
- Coronary disease complicates treatment decisions
- Difficulty achieving target TSH despite apparent adequate dosing (suggests malabsorption, non-adherence, or drug interactions)
- Severe symptoms at presentation
- Central hypothyroidism is suspected (though TSH is elevated here, making this unlikely)
Bottom Line
This is straightforward overt hypothyroidism requiring treatment. Start low (12.5-25 mcg), go slow with dose adjustments, monitor at 6-8 weeks, and target age-appropriate TSH levels while avoiding overtreatment. The low T4 with elevated TSH removes any ambiguity about treatment necessity, regardless of the patient's age.